SyntheticMR to create new normative database for quantitative brain values
SyntheticMR is collaborating with Mahajan Imaging in New Delhi, India, to gather reference values for the Indian population.
SyntheticMR, an innovative software solutions company for Magnetic Resonance Imaging (MRI) announced today that they are initiating a collaboration with Mahajan Imaging to create a normative database of brain tissue volumes, including myelin correlated volume and myelin fraction, in a healthy Indian population of various age groups from 6 to 90 years of age. This normative database will help establish the normal quantitative values for intracranial volume(ICV), brain parenchymal volume (BPV), and brain parenchymal fraction (BPF) for different age groups of Indian population.
Ethical approval has been granted for the study which will involve seven hospitals across India. To secure and facilitate the transfer of the collected data, SyntheticMR has selected CARPL, an end-to-end development, testing, and deployment platform for medical imaging applications. SyntheticMR has previously used CARPL to run regulatory studies and is now leveraging its ability to perform on-site de-identification of imaging data before the data gets shared to a central CARPL cloud for further analyses. The study has already started and will complete in the second part of 2022.
"This will be an important study for establishing normative data for the evaluation of several neurological diseases. I am excited that this data originating from India will be closer to reality for several Asian countries, thus resulting in more accurate diagnosis and treatment with better clinical outcomes," says Dr. Harsh Mahajan, Founder & Chief Radiologist at Mahajan Imaging, the company which has contributed their MRI machine time at no cost for this study. He is also the principal investigator for this study.
This is a significant step for SyntheticMR on the Indian market,” says Deepak Sharma, Head of Sales at SyntheticMR India & SEA. “We are happy to collaborate with such influential institutions to further establish a normative reference data for the Indian population. We believe that this will strengthen our position in India. We are excited to collaborate so closely with CARPL and the team at Mahajan Imaging.”
”For additional information, please contact Deepak Sharma Head of Sales India & SEA +91 78 276 09440 , or Hege Nåbo, Marketing and Communications Manager, +46 70 327 24 21 hege.nabo@syntheticmr.com.
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from a single 5-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI KNEE and SyMRI SPINE provides multiple contrast images and quantitative data for knee and spine anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI KNEE and SyMRI SPINE is CE-marked. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden. For more information, visit www.syntheticmr.com.